These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17944582)

  • 21. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
    Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemic training and immunosuppressive agents reduce the intensity of ischemic reperfusion injury after kidney transplantation.
    Treska V; Molacek J; Kobr J; Racek J; Trefil L; Hes O
    Exp Clin Transplant; 2006 Jun; 4(1):439-44. PubMed ID: 16827640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair.
    Jones EA; Shoskes DA
    J Urol; 2000 Mar; 163(3):999-1004. PubMed ID: 10688038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion.
    Dias PH; Oliveira GA; Dias FG; Gomes Rde P; Tambara Filho R; Fraga Rd
    Acta Cir Bras; 2015 Feb; 30(2):127-33. PubMed ID: 25714692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats.
    Torras J; Cruzado JM; Riera M; Condom E; Duque N; Herrero I; Merlos M; Espinosa L; Lloberas N; Egido J; Grinyó JM
    Kidney Int; 1999 Nov; 56(5):1798-808. PubMed ID: 10571788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
    Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney.
    Badid C; Vincent M; McGregor B; Melin M; Hadj-Aissa A; Veysseyre C; Hartmann DJ; Desmouliere A; Laville M
    Kidney Int; 2000 Jul; 58(1):51-61. PubMed ID: 10886549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.
    Rodríguez-Iturbe B; Pons H; Quiroz Y; Gordon K; Rincón J; Chávez M; Parra G; Herrera-Acosta J; Gómez-Garre D; Largo R; Egido J; Johnson RJ
    Kidney Int; 2001 Jun; 59(6):2222-32. PubMed ID: 11380825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
    Saad SY; Arafah MM; Najjar TA
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):455-60. PubMed ID: 16855841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression by mycophenolate mofetil of the neointimal thickening caused by vascular injury in a rat arterial stenosis model.
    Fraser-Smith EB; Rosete JD; Schatzman RC
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1204-8. PubMed ID: 8531082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition.
    Quiroz Y; Pons H; Gordon KL; Rincón J; Chávez M; Parra G; Herrera-Acosta J; Gómez-Garre D; Largo R; Egido J; Johnson RJ; Rodríguez-Iturbe B
    Am J Physiol Renal Physiol; 2001 Jul; 281(1):F38-47. PubMed ID: 11399644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term treatment with mycophenolic acid increases bile flow in continuously perfused and cold-preserved rat livers and does not affect hepatic ischemia-reperfusion injury.
    Baron A; Bilzer M; Gerbes AL
    Transpl Int; 2002 Jun; 15(6):265-71. PubMed ID: 12072896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis.
    Vanegas V; Ferrebuz A; Quiroz Y; Rodríguez-Iturbe B
    Kidney Int; 2005 Sep; 68(3):1161-70. PubMed ID: 16105047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease.
    Zhang T; Wang L; Xiong X; Mao Z; Wang L; Mei C
    Biol Res; 2009; 42(4):437-44. PubMed ID: 20140299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension.
    Tapia E; Franco M; Sánchez-Lozada LG; Soto V; Avila-Casado C; Santamaría J; Quiroz Y; Rodríguez-Iturbe B; Herrera-Acosta J
    Kidney Int; 2003 Mar; 63(3):994-1002. PubMed ID: 12631080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of mycophenolate mofetil on renal interstitial fibrosis and epithelial-myofibroblast translation in adenine-induced renal failure rats].
    He CM; Zheng FL; Liu YP
    Zhonghua Nei Ke Za Zhi; 2008 Nov; 47(11):901-5. PubMed ID: 19080229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective antagonism of the postsynaptic alpha(1)-adrenoceptor is protective against ischemic acute renal failure in rats.
    Fujii T; Sugiura T; Ohkita M; Kobuchi S; Takaoka M; Matsumura Y
    Eur J Pharmacol; 2007 Nov; 574(2-3):185-91. PubMed ID: 17651724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.